SAM
BEAM icon

Sectoral Asset Management’s Beam Therapeutics BEAM Stock Holding History

Sectoral Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-63,500
Closed -$2.03M – 124
2023
Q2 		$2.03M Hold
63,500
– – 0.34% 84
2023
Q1 		$1.94M Hold
63,500
– – 0.37% 82
2022
Q4 		$2.48M Sell
63,500
-2,200
-3% -$98.5K 0.48% 72
2022
Q3 		$3.13M Buy
+65,700
New +$3.75M 0.62% 68

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sectoral Asset Management's BEAM Position: Q3 2023 in Review

Sectoral Asset Management sold out of Beam Therapeutics (BEAM) in Q3 2023, closing a stake of 63,500 shares — an estimated $2.03M sold.

Sectoral Asset Management first reported a position in BEAM in Q3 2022 and held it in 4 quarters. The position peaked at $3.13M in Q3 2022. 194 funds tracked by Wall St. Rank hold BEAM as of Q3 2023.

  • Sectoral Asset Management reported no remaining Beam Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Sectoral Asset Management sold 63,500 Beam Therapeutics shares in Q3 2023, an estimated $2.03M.
  • Sectoral Asset Management first reported a position in Beam Therapeutics in Q3 2022 and held it in 4 quarters.
  • Sectoral Asset Management's Beam Therapeutics position peaked at $3.13M in Q3 2022.
  • 194 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2023.

Based on Sectoral Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.